These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
WHY
HELEN OF TROY
|
|||||||||||
|
|
||||||||||
| Asset and employee light model | Diversified portfolio of leading brands | ||||||||||
|
|
||||||||||
| Strong cash flow | Sustainable tax advantage | ||||||||||
|
|
||||||||||
| Low capex needs | Integrated operating company | ||||||||||
|
|
||||||||||
| Disciplined capital allocation |
Proven ability to grow while
expanding margin
|
||||||||||
|
|
||||||||||
| Proven M&A track record |
History of thorough and
transparent disclosure
|
||||||||||
|
|
||||||||||
|
Outstanding people
and winning culture
|
Shareholder friendly
approach and focus
|
||||||||||
|
Dear Shareholders:
It is my pleasure to invite you to the 2024 Annual General Meeting of Shareholders (the “Annual Meeting”) of Helen of Troy Limited (the “Company”) and inform you that the Annual Meeting will be conducted online on Wednesday, August 21, 2024, starting at 11:00 a.m. Eastern Daylight Time. The Annual Meeting will be held in a virtual-only meeting format via live webcast at www.virtualshareholdermeeting.com/HELE2024. You will not be able to attend the Annual Meeting in person. Please review the instructions for virtual attendance included in the “
Attending and Participating in the Virtual Annual Meeting
” section of the accompanying Proxy Statement.
Shareholders will be able to listen, vote, and submit questions from their home or any remote location with Internet connectivity. You will need to provide your 16-digit control number that is on your Notice of Internet Availability of Proxy Materials (“Notice of Internet Availability”) or on your proxy card if you receive materials by mail. Details regarding how to attend the Annual Meeting online, how to vote and the business to be conducted at the Annual Meeting are more fully described in the accompanying Notice of Annual General Meeting of Shareholders and Proxy Statement.
We continue to encourage you to help us reduce printing and mailing costs and conserve natural resources by submitting your proxy with voting instructions via the Internet. It is convenient and saves us significant postage and processing costs. You may also submit your proxy via telephone or by mail if you received paper copies of the proxy materials. Instructions regarding all three methods of voting are included in the Notice of Internet Availability, the proxy card and the Proxy Statement.
At our Annual Meeting, we will vote on proposals (1) to elect the nine nominees to our Board of Directors (individually referred to as "Directors" and, collectively, the “Board”), (2) to provide advisory approval of the Company’s executive compensation and (3) to appoint Grant Thornton LLP as the Company’s auditor and independent registered public accounting firm for the 2025 fiscal year and to authorize the Audit Committee of the Board to set the auditor’s remuneration, and transact such other business as may properly come before the Annual Meeting. The accompanying Notice of Annual General Meeting of Shareholders and Proxy Statement contains information that you should consider when you vote your shares. For your convenience, you can appoint your proxy via touch-tone telephone or the Internet at:
1-800-690-6903 or
WWW.PROXYVOTE.COM
It is important that you vote your shares whether or not you plan to virtually attend the Annual Meeting. If you do not plan on attending the Annual Meeting, we urge each shareholder to promptly sign and return the enclosed proxy card or appoint your proxy by telephone or online so that your shares will be represented and voted at the Annual Meeting. If you plan to attend the Annual Meeting virtually, you may also vote online at that time. On behalf of the management team and the Board of the Company, we would like to extend a thank you to our associates for their outstanding efforts to support the Company this year and to you our shareholders for your continued support and confidence.
Sincerely,
Noel M. Geoffroy
Chief Executive Officer |
|||||||
| 2024 Proxy Statement |
3
|
||||
|
DATE AND TIME
|
LOCATION
|
WHO CAN VOTE
|
||||||||||||||||||
|
August 21, 2024 at 11:00 a.m., Eastern Daylight Time
|
Online only at www.virtualshareholdermeeting.com/HELE2024
|
The record date for determining shareholders entitled to receive notice of and to vote at the Annual Meeting is June 18, 2024
|
||||||||||||||||||
| Items of Business | Board Recommendation | |||||||
|
Proposal 1:
To elect the nine nominees to our Board of Directors
|
ü
FOR
each Director
nominee
|
|||||||
|
Proposal 2:
To provide advisory approval of the Company’s executive compensation
|
ü
FOR
|
|||||||
|
Proposal 3
: To appoint Grant Thornton LLP as the Company’s auditor and independent registered public accounting firm for the 2025 fiscal year and to authorize the Audit Committee of the Board of Directors to set the auditor’s remuneration
|
ü
FOR
|
|||||||
| Advance Voting Methods |
E-Proxy
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON AUGUST 21, 2024
.
In accordance with Securities and Exchange Commission (“SEC”) rules, we are furnishing proxy materials to our shareholders on the Internet, rather than by mail. We believe this e-proxy process expedites our shareholders’ receipt of proxy materials, lowers our costs and reduces the environmental impact of our Annual Meeting. The Notice, Proxy Statement and the Company’s 2024 Annual Report to Shareholders and any other related proxy materials are available on our hosted website at www.proxyvote.com. For additional information, please refer to the section
“Important Notice Regarding the Availability of Proxy Materials for the Shareholder Meeting”
in the Proxy Statement. The Notice of Internet Availability of Proxy Materials and, for shareholders who previously requested electronic or paper delivery, the proxy materials, are to be distributed to shareholders on or about July 10, 2024.
By Order of the Board of Directors,
Tessa N. Judge
Chief Legal Officer
July 10, 2024
|
|||||||
TELEPHONE
1-800-690-6903
|
||||||||
INTERNET
www.proxyvote.com
|
||||||||
| WHETHER OR NOT YOU EXPECT TO VIRTUALLY ATTEND THE ANNUAL MEETING, PLEASE SUBMIT YOUR PROXY AS SOON AS POSSIBLE. IF YOU DO VIRTUALLY ATTEND THE ANNUAL MEETING, YOU MAY REVOKE YOUR PROXY AND VOTE IN PERSON. MOST SHAREHOLDERS HAVE THREE OPTIONS FOR SUBMITTING THEIR PROXIES PRIOR TO THE ANNUAL MEETING: (1) VIA THE INTERNET, (2) BY PHONE OR (3) BY SIGNING AND RETURNING THE ENCLOSED PROXY. IF YOU HAVE INTERNET ACCESS, WE ENCOURAGE YOU TO APPOINT YOUR PROXY ON THE INTERNET. IT IS CONVENIENT, AND IT SAVES THE COMPANY SIGNIFICANT POSTAGE AND PROCESSING COSTS. | ||||||||
|
4
|
Helen of Troy | ||||
| Page | |||||||||||
| INDEX OF KEY GOVERNANCE AND RELATED INFORMATION | ||||||||||||||
| 2024 Proxy Statement |
5
|
||||
|
Helen of Troy Limited (NASDAQ: HELE) is a leading global consumer products company offering creative products and solutions for our customers through a diversified portfolio of well-recognized and widely-trusted brands. We go to market under a number of brands, some of which are licensed. Our portfolio of brands include OXO®, Hydro Flask®, Osprey®, Vicks®, Braun®, Honeywell®, PUR®, Hot Tools®, Drybar®, Curlsmith® and Revlon®, among others.
We have built leading market positions through new product innovation, product quality and competitive pricing. We operate in two business segments: Home & Outdoor and Beauty & Wellness.
|
|
||||
|
Fiscal 2024 concluded Phase II of our Transformation Strategy, which produced net sales and organic net sales growth and gross profit margin expansion. We expanded our Leadership Brands and international footprint with the acquisitions of Drybar, Osprey and Curlsmith. We strategically and effectively deployed capital to construct our new distribution facility in Gallaway, Tennessee, repurchased shares of our common stock, and repaid amounts outstanding under our long-term debt agreement. We began publishing an annual ESG Report, which summarizes our ESG strategy and performance, providing further transparency into our ESG efforts. During Phase II, we also initiated a global restructuring plan referred to as “Project Pegasus”, which included the creation of a North America Regional Market Organization responsible for sales and go-to market strategies for all categories and channels in the U.S. and Canada, and further centralization of certain functions under shared services. With fiscal year 2024 marking the conclusion of Phase II, we have delivered compound annual growth rates for net sales revenue of 5.1%, diluted Earnings Per Share (“EPS”) of 1.2% and adjusted diluted EPS of 2.0%.
|
|||||
|
Fiscal 2025 begins our Elevate for Growth Strategy, which provides our strategic roadmap through fiscal 2030. The long-term objectives of Elevate for Growth include continued organic sales growth, further margin expansion, and accretive capital deployment through strategic acquisitions, share repurchases and capital structure management. The Elevate for Growth Strategy includes an enhanced portfolio management strategy to invest in our brands and grow internationally based upon defined criteria with an emphasis on brand building, new product introductions and expanded distribution.
|
|
||||
|
We are continuing to execute our initiatives under Project Pegasus, which we expect to generate incremental fuel to invest in our brand portfolio and new capabilities. We intend to further leverage our operational scale and assets, including our new state-of-the-art distribution center, improved go-to-market structure with our North America RMO, and our expanded shared service capabilities. We also plan to complete the U.S. geographic consolidation of our Beauty & Wellness businesses, create a centralized marketing organization that embraces next-level data analytics and consumer insight capabilities, and further integrate our supply chain and finance functions within our shared services. Additionally, we are committed to fostering a winning culture and continuing our ESG efforts to support our Elevate for Growth Strategy.
|
|||||
|
6
|
Helen of Troy | ||||
|
Net sales revenue compound annual growth rate of 5.1% over the past five fiscal years
|
Operating income compound annual growth rate of 5.5% over the past five fiscal years
|
Adjusted operating income compound annual growth rate of 4.7% over the past five fiscal years
|
||||||||||||||||||
|
Diluted EPS from continuing operations compound annual growth rate of 1.2% over the past five fiscal years
|
Adjusted diluted EPS from continuing operations compound annual growth rate of 2.0% over the past five fiscal years
|
Adjusted EBITDA (as defined below) compound annual growth rate of 5.7% over the past five fiscal years
|
||||||||||||||||||
| 2024 Proxy Statement |
7
|
||||
| VOTING MATTERS: |
Voting
Recommendation
of the Board
|
|||||||
| Proposal | ||||||||
|
Elect the nine nominees to our Board of Directors
|
ü
FOR
each nominee
|
|||||||
|
Provide advisory approval of the Company’s executive compensation
|
ü
FOR
|
|||||||
|
Appoint Grant Thornton LLP as the Company’s auditor and independent registered public accounting firm for the 2025 fiscal year and to authorize the Audit Committee of the Board of Directors to set the auditor’s remuneration
|
ü
FOR
|
|||||||
|
8
|
Helen of Troy | ||||
|
Director
Since
|
Independent
Director
|
Board Committee
Membership
|
||||||||||||||||||||||||
| Director Primary Occupation | Age | A | C | N | G | |||||||||||||||||||||
|
Noel M. Geoffroy
Chief Executive Officer
Helen of Troy Limited
|
53
|
2024
|
|||||||||||||||||||||||
|
Timothy F. Meeker
Chairman
President & Principal
Meeker & Associates
|
77
|
2004
|
ü | n | |||||||||||||||||||||
|
Krista L. Berry
Retired, Chief Revenue Officer
Everlane Inc.
|
59
|
2017
|
ü | n | n | n | |||||||||||||||||||
|
Vincent D. Carson
Retired, Chief Legal Officer and Secretary
Helen of Troy Limited
|
64
|
2018
|
ü | n | n | ||||||||||||||||||||
|
Thurman K. Case
Retired, Chief Financial Officer
Cirrus Logic, Inc.
|
67
|
2017
|
ü |
n
,
E
|
n | ||||||||||||||||||||
|
Tabata L. Gomez
Chief Marketing Officer
McCormick & Company, Inc.
|
43
|
2022
|
ü | n | |||||||||||||||||||||
|
Elena B. Otero
Retired, Chief Marketing Officer - International
The Clorox Company
|
59
|
2022
|
ü | n | |||||||||||||||||||||
|
Beryl B. Raff
Retired, Chairman & CEO
Helzberg Diamond Shops, Inc.
|
73
|
2014
|
ü | n | |||||||||||||||||||||
|
Darren G. Woody
President & CEO
Jordan Foster Construction, LLC
|
64
|
2004
|
ü | n | n | n | |||||||||||||||||||
|
A
Audit
|
C
Compensation
|
N
Nominating
|
G
Corporate Governance
|
|||||||||||||||||||||||
|
E
Audit Committee Financial Expert
|
n | Chair | n | Member | ||||||||||||||||||||||
| 2024 Proxy Statement |
9
|
||||
| BOARD INDEPENDENCE | BOARD GENDER DIVERSITY | |||||||
|
|
|||||||
8/9 |
Industry / Product
Knowledge
|
6/9 |
Financial / Accounting
|
5/9 |
Mergers / Acquisitions
|
||||||||||||
6/9 |
Multinational
Operations
|
2/9 |
Information Technology /
Digital / Cybersecurity
|
9/9 |
Corporate Strategy /
Governance
|
||||||||||||
6/9 |
Sales / Marketing
|
||||||||||||||||
|
10
|
Helen of Troy | ||||
| Feature | Terms | |||||||
| Rigorous Performance Metrics | Established rigorous performance goals based on multiple metrics that are not duplicative between short-term and long-term incentive awards. | |||||||
| Long-Term Incentives | Established multi-year performance periods for long-term incentive awards, with minimum vesting periods for Company equity grants. | |||||||
| Pay for Performance |
Our executive compensation programs are designed to demonstrate our execution on our pay for performance philosophy. Approximately 88% of target CEO pay and an average of 55% of target pay (excluding Mr. Grass’s interim CFO compensation) for our other named executive officers in fiscal year 2024 was at risk based on performance of the Company.
|
|||||||
| 2024 Proxy Statement |
11
|
||||
|
12
|
Helen of Troy | ||||
| 2024 Proxy Statement |
13
|
||||
|
14
|
Helen of Troy | ||||
|
Proposal 1: Election of Directors
The bye-laws of the Company state the number of our Directors shall be established by the Board of Directors from time to time but shall not be less than two. The Board of Directors has fixed the number of Directors at nine members.
Each nominee has consented to serve as a Director if elected. Based on the recommendation of the Nominating Committee, the Board of Directors has nominated the nine candidates set forth below for election to the Board of Directors. All of the nominees, except for Noel Geoffroy, were elected as directors by shareholders at the 2023 annual general meeting of shareholders and are being presented for re-election at the Annual Meeting. Ms. Geoffroy, who was appointed to the Board of Directors upon her succession as the Company’s Chief Executive Officer on March 1, 2024, is not considered an independent Director as defined in the applicable listing standards for companies traded on the NASDAQ Stock Market LLC (“NASDAQ”). The Board of Directors has determined that the remaining eight candidates, Krista L. Berry, Vincent D. Carson, Thurman K. Case, Tabata L. Gomez, Timothy F. Meeker, Elena B. Otero, Beryl B. Raff, and Darren G. Woody are considered independent Directors. Therefore, the majority of persons nominated to serve on our Board of Directors are independent as so defined. Each Director elected shall serve as a Director until the next annual general meeting of shareholders or until his or her successor is elected or appointed.
Vote Required for Approval and Recommendation
The receipt of a majority of the votes cast (the number of shares voted “for” a Director nominee exceeding the number of votes cast “against” that nominee) at the Annual Meeting is required to elect each of the nine nominees for Director. In the event that any of the Company’s nominees are unable to serve, proxies will be voted for the substitute nominee or nominees designated by our Board of Directors, or will be voted for fewer than nine nominees, as the Board may deem advisable in its discretion.
|
|||||||||||||||||
| ü |
THE BOARD OF DIRECTORS RECOMMENDS THAT THE SHAREHOLDERS VOTE “FOR” EACH OF THE NINE NOMINEES SET FORTH BELOW.
|
||||||||||||||||
| 2024 Proxy Statement |
15
|
||||
|
NOEL M. GEOFFROY
|
||||
|
CEO and Director Since:
2024
|
|||||
|
Committees:
None
Age:
53
|
|||||
|
Biographical Information
Ms. Geoffroy joined the Company in May 2022 and has served as its CEO since March 1, 2024. Prior to her appointment as the CEO, she served as the Company’s COO. Prior to joining the Company, Ms. Geoffroy served as Head of North America Consumer Healthcare at Sanofi S.A., a global healthcare company, and had held such position since January 2019. Prior to that time, she served in various leadership roles from December 2012 to December 2018 at Kellogg Company, an American multinational food manufacturing company, most recently President, US Frozen Foods. Ms. Geoffroy earned her undergraduate degree from Clemson University and her MBA from the University of Virginia.
Key Qualifications
Ms. Geoffroy brings over 25 years of experience in consumer-facing businesses at recognized brands and organizations, an innovative mindset, operational expertise, and seasoned leadership skills. As our CEO, Ms. Geoffroy provides essential oversight of the business and organization, and a link between management and the Board of Directors. She provides crucial insight to the Board on the Company’s strategic planning and operations. Ms. Geoffroy also plays a key role in communication with shareholders and in leading the Company’s organizational vision and strategy. Ms. Geoffroy also oversees the global business and the strategy and execution of several of the Company’s major transformation projects, a continuation from her time as COO.
|
|||||
|
16
|
Helen of Troy | ||||
|
TIMOTHY F. MEEKER | ||||
|
Director Since:
2004
Chairman Since:
2014
|
|||||
|
Committees:
Nominating (Chair)
Age:
77
|
|||||
|
Biographical Information
Since 2002, Mr. Meeker has served as President & Principal at Meeker and Associates, a privately-held management consulting firm. Mr. Meeker served as Senior Vice President, Sales & Customer Development for Bristol-Myers Squibb, a consumer products and pharmaceutical company, from 1996 through 2002. From 1989 to 1996, Mr. Meeker served as Vice President of Sales for Bristol-Myers’ Clairol Division.
Key Qualifications
Mr. Meeker has over forty years of experience in the consumer products industry resulting in extensive general management experience with responsibilities for sales, distribution, finance, human resources, customer service and facilities. In addition, he has a valued perspective on operational matters that is an asset to the Board of Directors. Mr. Meeker has served as a chairman of the National Association of Chain Drug Stores advisory committee, which allows him to bring an extensive understanding of retail mass market sales and marketing to our Board of Directors.
|
|||||
|
KRISTA L. BERRY | ||||
|
Director Since:
2017
|
|||||
|
Committees:
Audit, Nominating and Corporate Governance (Chair)
Age:
59
|
|||||
|
Biographical Information
Ms. Berry most recently served as the Chief Revenue Officer at Everlane Inc., a digitally based retail start up, from 2017 to 2018. Prior to that, Ms. Berry served as the Chief Digital Officer and Executive Vice President of Multi Channel of Kohl’s Corporation, a department store retail chain, from 2012 to 2016. Prior to her tenure at Kohl’s, Ms. Berry served as the General Manager of North America Direct to Consumer at Nike, Inc., a multinational footwear, apparel, equipment, accessories, and services company, from 2009 to 2011, and as General Manager of North America Digital Commerce from 2007 to 2009. Ms. Berry also held various management positions and leadership roles at Target Corporation, a retail company, from 1987 to 2007. Ms. Berry serves as an Advisory Board Member of Amer Sports. Previously, Ms. Berry served on the Board of Directors of BazaarVoice from 2017 to 2019.
Key Qualifications
Ms. Berry brings retail and direct to consumer leadership experience in global brands and startups to the Board of Directors, with over twenty years of digital experience, as well as critical knowledge surrounding consumer insights, digital data, social media and product merchandising.
|
|||||
| 2024 Proxy Statement |
17
|
||||
|
VINCENT D. CARSON | ||||
|
Director Since:
2018
|
|||||
|
Committees:
Compensation and Nominating
Age:
64
|
|||||
|
Biographical Information
In August 2018, Mr. Carson retired from his positions as the Company’s Chief Legal Officer and Secretary, which he had held since May 2014. Prior to his appointment as Chief Legal Officer and Secretary, he served in the capacity of Vice President, General Counsel and Secretary from November 2001 to September 2010. From September 2010 to April 2014, he served as Senior Vice President, General Counsel, and Secretary of the Company. Prior to joining the Company, Mr. Carson had a 16-year legal career in private practice in El Paso, Texas.
Key Qualifications
As a result of his prior service as the Company’s Chief Legal Officer and Secretary, Mr. Carson brings his unique knowledge of the Company and our industry to the Board of Directors. This experience and knowledge of the Company’s structure, the consumer products industry and Federal, state, local and foreign jurisdictions bring great value and benefit to our Board of Directors and the Company.
|
|||||
|
THURMAN K. CASE | ||||
|
Director Since:
2017
|
|||||
|
Committees:
Audit (Chair) and Corporate Governance
Age:
67
|
|||||
|
Biographical Information
Mr. Case was the Chief Financial Officer of Cirrus Logic, Inc., a leader in high performance, low-power integrated circuits for audio and voice signal processing applications, from February 2007 to May 2022. Prior to that, Mr. Case served in various positions at Cirrus Logic, including as Vice President, Treasurer, Financial Planning and Analysis from 2004 to 2007, Vice President, Finance from 2002 to 2004, and Director of Finance from 2000 to 2002. Before his tenure at Cirrus Logic, Mr. Case served in a variety of financial leadership positions, including at Case Associates, Inc. and Public Service Company of New Mexico, an electric utilities company. Mr. Case serves on the Board of Directors for Triad Semiconductor. Mr. Case received a Bachelor of Economics degree and a Master of Business Administration from New Mexico State University.
Key Qualifications
Mr. Case brings broad experience in business strategy, operations, accounting, information technology, mergers and acquisitions, auditing and SEC reporting matters to the Board of Directors. In addition, his experience as a public company executive contributes to his knowledge of corporate governance and public company matters.
|
|||||
|
18
|
Helen of Troy | ||||
|
TABATA L. GOMEZ | ||||
|
Director Since:
2022
|
|||||
|
Committees:
Corporate Governance
Age:
43
|
|||||
|
Biographical Information
Ms. Gomez has served as the Chief Marketing Officer of McCormick & Company Inc. (
“
McCormick
”), a spice and extract manufacturing company, since November 2023.
In her role, she leads the global marketing organization and is a member of the Global Operating Committee of McCormick. Prior to joining McCormick, Ms. Gomez had served as Chief Marketing Officer for the Tools & Outdoor segment of Stanley Black & Decker Inc., a manufacturer of industrial tools and household hardware, since September 2022, where she oversaw a $14 billion portfolio of brands. She also served as President of the Global Hand Tools, Accessories & Storage Group, a business unit within Stanley Black & Decker, Inc. Prior to her time at Stanley Black & Decker, Ms. Gomez worked at Coty, Inc., a manufacturer and marketer of fragrances, cosmetics, hair care and other beauty products, where she was Vice President of Rimmel. She also spent 13 years at The Procter & Gamble Company in the United States, Europe, and Latin America where she served in roles of increasing responsibility in brand management, marketing and innovation. Ms. Gomez holds a Bachelor of Arts in International Relations from the Universidad Iberoamericana in Mexico City and she speaks several languages.
Key Qualifications
Ms. Gomez brings expertise in global marketing, brand leadership, profit & loss management a
nd licensed product management to the Board of Directors. With broad international experience in Latin America, Europe and Asia, Ms. Gomez also provides the Board with critical international perspectives.
|
|||||
|
ELENA B. OTERO | ||||
|
Director Since:
2022
|
|||||
|
Committees:
Compensation
Age:
59
|
|||||
|
Biographical Information
Ms. Otero is a former executive in the international division of The Clorox Company, a manufacturer and marketer of consumer products, where she served as Chief Marketing Officer, eCommerce Officer and Strategy & Growth Officer from 2016 until her retirement in 2021. She previously served as Vice President of Marketing and General Manager of Clorox’s Home Care International business unit from 2010 to 2016 and as Vice President of Marketing and General Manager of Clorox’s Greenworks International business unit from 2008 to 2010. Prior to these roles, Ms. Otero held leadership positions in Latin America from 2002 to 2008, including responsibility for Clorox’s business operations in Puerto Rico, the Caribbean, Central America and South America. Prior to that, from 1990 to 2002, Ms. Otero held marketing leadership positions across multiple categories and brands at The Procter & Gamble Company.
Key Qualifications
Ms. Otero brings to the Board of Directors over thirty years of global consumer products experience, primarily in marketing, growth and strategy, ecommerce, and general management. Her experience in leading global marketing across forty countries also provides the Board with critical international perspectives.
|
|||||
| 2024 Proxy Statement |
19
|
||||
|
|
|||||
|
BERYL B. RAFF
|
||||
|
Director Since:
2014
|
|||||
|
Committees:
Audit
Age:
73
|
|||||
|
|
|||||
|
Biographical Information
Since April 2009 until her retirement in July 2022, Ms. Raff served as Chairman and Chief Executive Officer at Helzberg Diamond Shops Inc. (“Helzberg Diamonds”), a jewelry retailer and a wholly-owned subsidiary of Berkshire Hathaway Inc. Through June 2023, Ms. Raff continued to advise and consult the Helzberg Diamonds’ executive team as non-executive Chairman of the Board. From 2005 through April 2009, she served as Executive Vice President-General Merchandise Manager for the fine jewelry division of J.C. Penney Company, Inc., a retailer of apparel and home furnishings. From 2001 through 2005, Ms. Raff served as Senior Vice President-General Merchandise Manager for the fine jewelry division of J.C. Penney. Prior to joining J.C. Penney, Ms. Raff served in various leadership roles at Zale Corporation, a national retail jewelry chain, last serving as its Chairman and Chief Executive Officer. In May 2021, Ms. Raff was appointed to the Board of Directors of Academy Sports and Outdoors, Inc., where she serves as the Chair of the Compensation Committee. Ms. Raff served on the Board of Directors of Group 1 Automotive, Inc., an automotive retail operator, from 2007 to 2015. At Group 1 she was a member of the Compensation Committee of its Board of Directors and Chair of the Governance/Nomination Committee. Ms. Raff served on the Board of Directors of The Michaels Companies, Inc. from September 2014 through April 2021, a national retail chain of arts and crafts specialty stores, and was a member of its Compensation Committee. Ms. Raff has previously served as a Director of the NACD Heartland Chapter, a non-profit organization dedicated to excellence in board leadership. From 2001 through February 2011, Ms. Raff served on the Board of Directors, the Corporate Governance Committee and the Compensation Committee (which she chaired from 2008 to 2011) of Jo-Ann Stores, Inc., a national specialty retailer of craft, sewing and decorating products. Ms. Raff graduated from Boston University with a Bachelor of Business Administration degree and from Drexel University with a Master of Business Administration.
Key Qualifications
Ms. Raff is well known throughout the retail industry and brings to the Board of Directors her experience and perspective as an outstanding merchant and multi-store retail executive. The Board benefits from Ms. Raff’s extensive knowledge of the retail industry and her valuable insight on how the Company can best serve its retail partners. Ms. Raff’s current and previous service on other boards, including public companies, also provides important perspectives on key corporate governance matters.
|
|||||
|
|
|||||
|
20
|
Helen of Troy | ||||
|
DARREN G. WOODY | ||||
|
Director Since:
2004
|
|||||
|
Committees:
Compensation (Chair), Nominating and Corporate Governance
Age:
64
|
|||||
|
Biographical Information
Mr. Woody is President and Chief Executive Officer of Jordan Foster Construction, LLC, a construction firm with offices in Austin, Dallas, El Paso, Houston, and San Antonio, Texas and field operations throughout the Southwest. The firm specializes in highway, military, commercial, and multi-family construction. He has served in this capacity since August of 2000. Previously, Mr. Woody was a partner in the law firm of Krafsur, Gordon, Mott, Davis and Woody P.C., where he specialized in real estate, business acquisitions and complex financing arrangements. Mr. Woody also served on the Board of Directors of Construction Insurance and Risk Captive of America, Limited (CIRCA), a licensed group reinsurance company from 2021 to 2023.
Key Qualifications
Mr. Woody brings a multi-disciplined perspective to our Board of Directors given his executive leadership and legal experience. This background enables him to provide valuable input with regard to many of the Company’s legal matters, significant transactional negotiations and the management of challenging complex projects.
|
|||||
| BOARD INDEPENDENCE | BOARD GENDER DIVERSITY | |||||||
|
|
|||||||
| 2024 Proxy Statement |
21
|
||||
| Geoffroy | Meeker | Berry | Carson | Case | Gomez | Otero | Raff | Woody | |||||||||||||||||||||
|
Key Areas of Skills and Experience
|
|||||||||||||||||||||||||||||
|
Industry / Product
Knowledge
|
n | n | n | n | n | n | n | n | |||||||||||||||||||||
|
Multinational
Operations
|
n | n | n | n | n | n | |||||||||||||||||||||||
| Sales / Marketing | n | n | n | n | n | n | |||||||||||||||||||||||
| Financial / Accounting | n | n | n | n | n | n | |||||||||||||||||||||||
|
Information Technology /
Digital / Cybersecurity
|
n | n | |||||||||||||||||||||||||||
| Mergers / Acquisitions | n | n | n | n | n | ||||||||||||||||||||||||
|
Corporate Strategy /
Governance
|
n | n | n | n | n | n | n | n | n | ||||||||||||||||||||
|
Board Diversity Matrix -
Demographic Background
(as of June 21, 2024)
|
|||||||||||||||||||||||||||||
| Gender Expression | Female | Male | Female | Male | Male | Female | Female | Female | Male | ||||||||||||||||||||
| Hispanic or Latinx | n | n | |||||||||||||||||||||||||||
| White | n | n | n | n | n | n | n | ||||||||||||||||||||||
|
22
|
Helen of Troy | ||||
| 2024 Proxy Statement |
23
|
||||
|
24
|
Helen of Troy | ||||
|
Our Audit Committee
|
Our Compensation Committee
|
Our Nominating Committee
|
Our Governance Committee
|
||||||||
|
Directly oversees risk management relating to financial reporting, public disclosure, legal and regulatory compliance, data protection and cybersecurity. Additionally, periodically reviews with management the Company's disclosure controls and procedures, internal controls for financial reporting purposes and systems and procedures. Also responsible for assessing the steps management has taken to monitor and control these risks and exposures and evaluating guidelines and policies with respect to our risk assessment and risk management.
|
Directly oversees risk management relating to associate compensation, including any risks of compensation programs encouraging excessive risk-taking. For further information, see “
Executive Compensation– Compensation Risks
.”
|
Directly oversees risk management relating to Director nomination, including periodically assessing, developing and communicating with the Board concerning the appropriate criteria for nominating and appointing directors. Also considers matters associated with the independence of our Board. Additionally, oversees an annual review of the performance of the Board and its committees.
|
Directly oversees risk management regarding corporate governance, including periodically assessing the effectiveness of the Company's corporate governance policies in light of the applicable listing standards and laws. Also oversees programs relating to ESG matters and periodically evaluates the effectiveness of the Company's ESG programs and policies. Additionally, periodically evaluates the effectiveness of the Company's succession plans for the Company's senior management.
|
||||||||
| 2024 Proxy Statement |
25
|
||||
|
26
|
Helen of Troy | ||||
|
Committee Chair
Thurman K. Case
Members
Krista L. Berry
Beryl B. Raff
FY24 Meetings
4
|
The Audit Committee is established in accordance with Section 3(a)(58)(A) of the Exchange Act and operates under a written charter that has been adopted by the Board of Directors.
The primary purposes and responsibilities of the committee are to oversee, on behalf of the Company’s Board of Directors:
(1)
the accounting and financial reporting processes and integrity of the Company’s financial statements,
(2)
the audits of the Company’s financial statements and the appointment, compensation, qualifications, independence, and performance of our independent registered public accounting firm,
(3)
our compliance with legal and regulatory requirements,
(4)
the staffing and ongoing operation of our internal audit function, and
(5)
working with the full Board, risks related to data protection and cybersecurity.
Other responsibilities:
▪
Meets periodically with our CFO and other appropriate officers in the discharge of its duties
▪
Reviews the content and enforcement of the Company’s Code of Ethics
▪
Consults with legal counsel on various legal compliance matters and on other legal matters if those matters could materially affect our financial statements
The Board of Directors has determined that each of the members of the Audit Committee is independent as previously described. In addition, the Board of Directors determined that Mr. Case qualifies as the “audit committee financial expert” (as defined by in Item 407(d)(5) of Regulation S-K promulgated by the SEC). Additionally, the Board of Directors determined that all of the members of the Audit Committee meet the requirement of the NASDAQ listing standards that each member be able to read and understand fundamental financial statements, including a company’s balance sheet, income statement and cash flow statement.
|
||||||||||
| 2024 Proxy Statement |
27
|
||||
|
Committee Chair
Darren G. Woody
Members
Elena B. Otero
Vincent D. Carson
FY24 Meetings
4
|
The Compensation Committee operates under a written charter that has been adopted by the Board of Directors.
The primary purposes and responsibilities of the committee are to:
(1)
evaluate and approve the corporate goals and objectives set by the CEO,
(2)
evaluate the CEO’s performance in light of those goals and objectives,
(3)
make recommendations to the Board of Directors with respect to CEO and other NEO compensation, incentive compensation plans and equity-based plans,
(4)
oversee the administration of our incentive compensation plans and equity-based plans,
(5)
make recommendations with respect to non-employee director compensation,
(6)
review and discuss with management the Company’s Compensation Discussion & Analysis required by SEC rules and regulations to be included in the Company’s Proxy Statement and annual report on Form 10-K, and
(7)
produce an annual report on executive compensation for inclusion in the Company’s proxy statement.
The Board of Directors has determined that the members of this committee are independent as previously described. In addition to formal meetings, the committee also conducted numerous informal telephonic discussions and consulted its legal advisors and independent compensation consultant throughout the year. The Compensation Committee has the independent authority to hire compensation, accounting, legal, or other advisors. The Compensation Committee engaged Frederic W. Cook & Company (“FW Cook”) as its independent compensation consultant to assist the Compensation Committee with its compensation decisions for our named executive officers and Directors for fiscal year 2024. The Compensation Committee has determined that FW Cook had no conflicts of interest relating to its engagement by the Compensation Committee.
|
||||||||||
|
28
|
Helen of Troy | ||||
|
Committee Chair
Timothy F. Meeker
Members
Krista L. Berry
Darren G. Woody
Vincent D. Carson
FY24 Meetings
3
|
The Nominating Committee operates under a written charter that has been adopted by the Board of Directors.
The primary purposes and responsibilities of the Nominating Committee are to:
(1)
recommend to our Board of Directors individuals qualified to serve on our Board of Directors for election by shareholders at each annual general meeting of shareholders and to fill vacancies on the Board of Directors, and
(2)
develop and communicate with the Board criteria for selecting new Directors.
Other responsibilities:
▪
Oversees the evaluation of the Directors and seeks to annually review Director qualifications and skill sets with the goal of maintaining fresh perspectives on the Board and complementing the skill sets of the other Directors
▪
Receives recommendations from its members, other members of the Board of Directors, outside advisors, and consultants for candidates to be considered for the Board
▪
Receives recommendations from its members or other members of the Board of Directors for candidates to be appointed to committee positions, reviews and evaluates such candidates and makes recommendations to the Board of Directors for nominations to fill or add committee positions
|
||||||||||
|
Committee Chair
Krista L. Berry
Members
Thurman K. Case
Tabata L. Gomez
Darren G. Woody
FY24 Meetings
4
|
The Governance Committee operates under a written charter that has been adopted by the Board of Directors.
The primary purposes and responsibilities of the Governance Committee are to:
(1)
develop, assess and recommend to the Board our corporate governance policies,
(2)
evaluate, develop and recommend to the Board succession plans for all of our senior management, and
(3)
assist the Board in overseeing programs relating to ESG matters.
Other responsibilities:
▪
Works with the Compensation Committee to develop and recommend succession plans to the Board of Directors
▪
Periodically evaluate the effectiveness of ESG programs and policies in light of the Company’s corporate goals and objectives and, if appropriate, make recommendations to the Board
|
||||||||||
| 2024 Proxy Statement |
29
|
||||
|
30
|
Helen of Troy | ||||
| Committee |
Amount
($)
|
||||
|
Audit Committee
|
20,000 | ||||
| Compensation Committee | 20,000 | ||||
|
Nominating Committee
|
15,000 | ||||
| Governance Committee | 15,000 | ||||
| Name |
Fees Earned or
Paid in Cash
($)
(1)
|
Stock
Awards
($)
(2)
|
Total
($)
|
||||||||
|
Krista L. Berry
(3)
|
115,000 | 140,000 | 255,000 | ||||||||
|
Thurman K. Case
(4)
|
120,000 | 140,000 | 260,000 | ||||||||
| Vincent D. Carson | 100,000 | 140,000 | 240,000 | ||||||||
|
Tabata L. Gomez
|
100,000 | 140,000 | 240,000 | ||||||||
|
Timothy F. Meeker
(5)
|
230,000 | 140,000 | 370,000 | ||||||||
| Elena B. Otero | 100,000 | 140,000 | 240,000 | ||||||||
| Beryl B. Raff | 100,000 | 140,000 | 240,000 | ||||||||
|
Darren G. Woody
(6)
|
120,000 | 140,000 | 260,000 | ||||||||
| 2024 Proxy Statement |
31
|
||||
|
32
|
Helen of Troy | ||||
|
Proposal 2: Advisory Approval of the Company’s Executive Compensation
In accordance with Section 14A of the Exchange Act, we are asking shareholders to approve the following advisory resolution at the Annual Meeting:
RESOLVED, that the shareholders of Helen of Troy Limited approve, on an advisory basis, the compensation of the Company’s NEOs disclosed in the Compensation Discussion & Analysis, the Summary Compensation Table and the related compensation tables, notes and narratives in the Proxy Statement for the Company’s 2024 Annual General Meeting of Shareholders.
This advisory resolution, commonly referred to as a “say on pay” resolution, is non-binding on the Board of Directors. Although non-binding, the Board of Directors and the Compensation Committee will review and consider the voting results when making future decisions regarding our executive compensation program. The Board of Directors previously recommended, and the shareholders approved, holding an annual “say on pay” advisory resolution. Therefore, the Company’s next “say on pay” advisory resolution after the Annual Meeting will be presented at the 2025 annual general meeting of shareholders.
Our executive compensation program emphasizes performance- and equity-based compensation to align it with shareholder interests. In addition, our executive compensation program includes other practices that we believe serve shareholder interests such as paying for performance, establishing rigorous performance goals and maintaining clawback terms for incentive awards and prohibitions on hedging or pledging Company stock. The Compensation Committee believes that the Company’s executive compensation program uses appropriate structures and sound pay practices. Accordingly, the Compensation Committee recommends a vote “For” this Proposal 2.
When casting your vote, we urge shareholders to read the Compensation Discussion & Analysis, which describes in more detail how our executive compensation policies and procedures operate and are designed to achieve our compensation objectives.
|
|||||||||||||||||
| ü | THE BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR” THIS PROPOSAL. | ||||||||||||||||
| 2024 Proxy Statement |
33
|
||||
|
JULIEN R. MININBERG
Chief Executive Officer (Retired)
|
CEO Since:
2014
Retired:
2024
Age:
59
|
||||||
|
Mr. Mininberg joined the Company in 2006 and served as its CEO from 2014 through his retirement on February 29, 2024. Prior to his appointment as Helen of Troy’s CEO, he had served as the CEO of Kaz, a wholly-owned subsidiary of the Company since December 2010. Before joining the Company, Mr. Mininberg worked for 15 years at The Procter & Gamble Company where he spent an equal amount of time in the United States and Latin America serving in a variety of marketing and general management capacities.
|
||||||||
|
NOEL M. GEOFFROY
Chief Operating Officer/Chief Executive Officer (Successor)
|
COO:
2022 to 2023
CEO Since:
2024
Age:
53
|
||||||
|
Ms. Geoffroy joined the Company in May 2022 to serve as its COO and has served as the Company’s CEO since March 1, 2024. Prior to joining the Company, Ms. Geoffroy served as Head of North America Consumer Healthcare at Sanofi S.A., a global healthcare company, and held such position since January 2019. Prior to that time, she served in various leadership roles from December 2012 to December 2018 at Kellogg Company, an American multinational food manufacturing company, most recently President, US Frozen Foods.
|
||||||||
|
34
|
Helen of Troy | ||||
|
BRIAN l. GRASS
Chief Financial Officer
|
CFO Since:
2023
Age:
54
|
||||||
|
Mr. Grass joined the Company in 2006 and previously served as its CFO from 2014 until his retirement in 2021. Mr. Grass rejoined the Company in March 2023 to serve as Senior Vice President, Assistant Chief Financial Officer and began to serve as interim CFO on April 28, 2023. He was appointed to serve as CFO effective September 23, 2023. Prior to his appointment as the CFO in 2014, he served as the Company’s Assistant CFO. Prior to joining the Company, Mr. Grass spent seven years in public accounting at KPMG LLP and six years in various financial leadership roles at Tenet Healthcare Corporation, a healthcare services company.
|
||||||||
|
TESSA N. JUDGE
Chief Legal Officer
|
CLO Since:
2022
Age:
40
|
||||||
|
Ms. Judge joined the Company in 2015 and has served as its Chief Legal Officer (“CLO”) since March 2022. She joined the Company in March 2015 as Assistant General Counsel and was promoted to General Counsel in August 2018. Prior to joining the Company, Ms. Judge worked as an attorney at the international law firm of Akin Gump Strauss Hauer & Feld LLP for seven years.
|
||||||||
| 2024 Proxy Statement |
35
|
||||
|
Title
|
Leadership Change
|
|||||||
| Julien R. Mininberg |
Chief Executive Officer (Retired)
|
Retired as CEO on February 29, 2024
|
||||||
| Noel M. Geoffroy |
Chief Operating Officer
Chief Executive Officer
|
Served as COO through February 29, 2024
Appointed as CEO effective March 1, 2024
|
||||||
|
Brian L. Grass
|
Chief Financial Officer |
Appointed as interim CFO on April 28, 2023 and CFO on September 23, 2023
|
||||||
| Matthew J. Osberg | Former Chief Financial Officer |
Resigned as Chief Financial Officer on April 27, 2023
|
||||||
|
Net sales revenue compound annual (decline) growth rates of (1.5)% and 5.1% over the past three and five fiscal years, respectively
|
Operating income compound annual (decline) growth rates of (2.5)% and 5.5% over the past three and five fiscal years, respectively
|
Adjusted operating income compound annual (decline) growth rates of (3.4)% and 4.7% over the past three and five fiscal years, respectively
|
||||||||||||||||||
|
Diluted EPS from continuing operations compound annual (decline) growth rates of (11.3)% and 1.2% over the past three and five fiscal years, respectively
|
Adjusted diluted EPS from continuing operations compound annual (decline) growth rates of (8.6)% and 2.0% over the past three and five fiscal years, respectively
|
Adjusted EBITDA (as defined below) compound annual (decline) growth rates of (1.8)% and 5.7% over the past three and five fiscal years, respectively
|
||||||||||||||||||
|
36
|
Helen of Troy | ||||
|
THREE-YEAR CUMULATIVE RETURN BASE YEAR = 2021
|
||
|
||
|
FIVE-YEAR CUMULATIVE RETURN BASE YEAR = 2019
|
||
|
||
| 2024 Proxy Statement |
37
|
||||
| Feature | Terms | |||||||
| Rigorous Performance Metrics | Established rigorous performance goals based on multiple metrics that are not duplicative between short-term and long-term incentive awards. | |||||||
| Long-Term Incentives | Established multi-year performance periods for long-term incentive awards, with minimum vesting periods for Company equity grants. | |||||||
| Pay for Performance |
Our executive compensation programs are designed to demonstrate our execution on our pay for performance philosophy. In fiscal year 2024, as described below, approximately 88% of target CEO pay and 55%, on average, of target pay (excluding Mr. Grass’s interim CFO compensation) for our other NEOs was at risk based on the performance of the Company. In fiscal year 2025, approximately 68% of target CEO pay is expected to be at risk based on the performance of the Company (excluding a one-time promotion time-vested long-term incentive award).
|
|||||||
|
38
|
Helen of Troy | ||||
|
CEO TARGET PAY MIX
FISCAL YEAR 2024
(1)
|
OTHER NEOs TARGET PAY MIX
FISCAL YEAR 2024
(2)
(Average)
|
||||
|
|
||||
| 2024 Proxy Statement |
39
|
||||
|
40
|
Helen of Troy | ||||
|
Executive Officer
|
Compensation Changes
|
|||||||
|
Ms. Geoffroy (Chief
Operating Officer
and Chief Executive
Officer (Successor))
|
For fiscal year 2024, in connection with the transition of her role as COO to CEO:
▪
an annual base salary of $800,000;
▪
eligibility to receive an annual performance bonus payable in cash at a target of 125% of her base salary under the Annual Bonus Plan; and
▪
eligibility to receive long-term incentive awards under the Company’s 2018 Stock Plan at a target of $1,600,000 (grant date fair value), consisting of a combination of (1) Performance RSAs based on performance goals and a three-year performance period (75% of total award) and (2) time-vested Restricted Stock Awards (“RSAs”) that will vest equally over a three-year period (25% of total award).
|
|||||||
|
For fiscal year 2025, in connection with her assuming the position of CEO on March 1, 2024:
▪
an annual base salary of $1,000,000;
▪
eligibility to receive an annual performance bonus payable in cash at a target of 125% of her base salary under the Annual Bonus Plan with a maximum payout of 200% of target;
▪
eligibility to receive long-term incentive awards under the Company’s 2018 Stock Plan at a target of $3,800,000 (grant date fair value);
▪
long-term incentive awards will be a combination of (1) Performance RSAs based on performance goals and a three-year performance period (75% of total award) with a maximum payout of 200% of target and (2) time-vested RSAs that will vest equally over a three-year period (25% of total award);
▪
a one-time promotion long-term incentive award under the 2018 Stock Plan of $500,000 (grant date fair value), consisting of time-vested RSAs that will vest equally over a three-year period; and
▪
certain severance benefits that are substantially the same as the benefits under her existing Severance Agreement with the Company other than changes resulting from her new compensation levels as CEO.
|
||||||||
|
Mr. Grass (Chief
Financial Officer)
|
In connection with his appointment as interim CFO effective April 28, 2023 for a term ending September 22, 2023:
▪
a base salary for his six month term of $1,350,000; and
▪
a one-time sign-on incentive award under the 2018 Stock Plan of $450,000 (grant date fair value), consisting of Restricted Stock Units (“RSUs”) that vested at the end of his term.
For fiscal year 2024, in connection with his appointment as CFO on September 23, 2023:
▪
an annual base salary of $600,000;
▪
eligibility to receive an annual performance bonus payable in cash at a target of 85% of his base salary under the Annual Bonus Plan with a maximum payout of 200% of target;
▪
eligibility to receive long-term incentive awards under the Company’s 2018 Stock Plan at a target of $1,600,000 (grant date fair value), consisting of a combination of (1) Performance RSAs based on performance goals, and a three-year performance period (50% of total award) with a maximum payout of 200% of target and (2) time-vested RSAs that will vest equally over a three-year period (50% of total award); and
▪
the annual performance bonus and long-term incentive award are pro-rated based on the number of days from September 25, 2023 (the first business day after the effective date of his appointment as CFO) through the remainder of the fiscal year.
|
|||||||
|
Ms. Judge (Chief
Legal Officer)
|
A $21,500 increase to our CLO’s base salary effective March 1, 2023 to $496,500. In addition, our CLO’s target long-term incentive award was increased by $150,000.
|
|||||||
|
Mr. Osberg
(Former CFO)
|
Mr. Osberg, our former CFO, resigned on April 27, 2023. Prior to his resignation, the Compensation Committee approved a $25,000 increase to his base salary effective March 1, 2023 and certain increases to his target long-term incentive award and target annual cash performance bonus. Under the terms of his Severance Agreement, Mr. Osberg was not entitled to any portion of his fiscal year 2024 annual incentive award and forfeited his long-term incentive award upon his resignation.
|
|||||||
| 2024 Proxy Statement |
41
|
||||
| Element | Type | Terms | |||||||||||||||
| Base Salary | Cash |
▪
Fixed amount of compensation for performing day-
to-
day responsibilities.
▪
NEOs are generally eligible for annual increases.
|
|||||||||||||||
|
Annual Incentives
and Bonuses
|
Cash |
▪
Competitively-based annual incentive awards for achieving short-term financial goals (such as annual adjusted income and net sales targets) and other strategic objectives.
|
|||||||||||||||
|
Performance Long-
Term Incentives*
|
Performance Restricted Stock Awards (Performance RSAs)
|
▪
Performance RSAs vest at the end of a three-year performance period.
▪
Performance RSA goals are competitively designed to achieve long-term financial goals (such as cumulative adjusted diluted EPS and relative total shareholder return performance metrics) and other strategic objectives.
|
|||||||||||||||
|
Time-Vested Long-
Term Incentives*
|
Time-Vested RSAs or RSUs
|
▪
Time-vested RSAs vest equally over a three-year period.
▪
One-time sign-on incentive award (RSUs) to Mr. Grass that vested on September 22, 2023.
|
|||||||||||||||
| Other | Perquisites |
▪
No excessive perquisites.
|
|||||||||||||||
|
42
|
Helen of Troy | ||||
| 2024 Proxy Statement |
43
|
||||
|
The Clorox Company
Church & Dwight Co., Inc.
Coty Inc.
Edgewell Personal Care
Company
|
Energizer Holdings, Inc.
La-Z-Boy Incorporated
Newell Brands Inc.
Nu Skin Enterprises, Inc.
Prestige Consumer Healthcare Inc.
|
Revlon, Inc.
(1)
Spectrum Brands Holdings, Inc.
Tempur Sealy International, Inc.
Tupperware Brands Corporation
Yeti Holdings, Inc.
|
||||||
|
44
|
Helen of Troy | ||||
| WHAT WE DO | WHAT WE DO NOT DO | |||||||
Pay for Performance
– We heavily link our executive compensation program to the Company’s operating performance and the Compensation Committee’s evaluation of individual performance. We ensure that a significant portion of our NEOs’ compensation opportunities are performance-based. The amount of the payout to our NEOs is contingent on the degree to which the Company achieves pre-established performance goals that the Compensation Committee has determined are aligned with the Company’s short- and long-term operating and financial objectives.
Focused Incentive Goals
– Our annual and long-term incentive programs include multiple and rigorous performance goals that are not duplicative between short-term and long-term incentive awards. Long-term awards are measured over a three-year period. By using different performance measures in our annual cash incentive program and our long-term stock incentive program, we mitigate the risk that our NEOs would be motivated to pursue results with respect to one performance measure to the detriment of the Company as a whole.
Compensation Recoupment Policies
– In order to discourage excessive risk-taking and misconduct on the part of executive officers, our incentive plans and the employment and severance agreements with our current NEOs include a clawback provision. In fiscal year 2024, in line with newly-adopted SEC rules and NASDAQ listing standards, the Board of Directors also adopted a clawback policy to require the Company to seek recovery of erroneously awarded incentive-based compensation received by our executive officers, including NEOs, during any three-fiscal-year period prior to the date the Company is required to prepare an accounting restatement due to material noncompliance with any financial reporting requirement under the securities laws.
|
No Incentive Compensation Performance Goals that Would Encourage Unnecessary or Excessive Risk Taking
- Our annual and long-term incentive programs are designed to incorporate performance criteria that promote our short-term and long-term business strategies, build long-term shareholder value and discourage excessive risk-taking.
No Guaranteed Bonuses
- Cash bonuses are not guaranteed for our NEOs.
No Single Trigger Payments upon a Change of Control
- We do not provide “single trigger” cash payments that are prompted solely by a change of control and unvested equity awards granted to NEOs do not provide for accelerated vesting or settlement solely upon a change of control when the surviving company assumes the equity awards.
No Tax Gross-Ups on Change of Control Payments
- We do not provide any tax gross-ups on change of control payments.
No Pledging of Common Stock
– Our Insider Trading Policy prohibits Directors and our NEOs from pledging Common Stock. None of our Directors or executive officers have any existing pledging arrangements.
No Use of Common Stock as Collateral for Margin Loans
- Directors and our NEOs are prohibited from using Common Stock as collateral for any margin loan.
No Excessive Perquisites
– Consistent with our culture, we do not provide excessive perquisites to our executives.
|
|||||||
| 2024 Proxy Statement |
45
|
||||
| WHAT WE DO | WHAT WE DO NOT DO | |||||||
Annual Shareholder “Say on Pay”
– Because we value our shareholders’ input on our executive compensation programs, our Board has chosen to provide shareholders with the opportunity each year to vote to approve, on a non-binding, advisory basis, the compensation of our NEOs in our Proxy Statement.
Limitation on Employment Contracts
– We employ all of our NEOs, other than our CEO, on an at-will basis. Each executive officer has post-termination and non-competition obligations with the Company pursuant to which the executive officer has agreed that he or she will not participate in a business that competes with us for a defined period of time.
Stock Ownership Guidelines
– Our executive officers are subject to certain stock ownership and holding requirements. The CEO is required to own Common Stock equal in value to at least four times annual salary, the CFO and COO are required to own Common Stock equal in value to at least two times annual salary and the CLO is required to own Common Stock equal in value to at least one times annual salary.
|
No Hedging
– Directors and our NEOs are prohibited from entering into transactions (such as trading in options) while serving as Directors or executive officers of the Company that are designed to hedge against the value of the Company’s Common Stock, which would eliminate or limit the risks and rewards of the Common Stock ownership.
No Speculative Trading
– Directors and our NEOs are prohibited from short-selling the Common Stock, buying or selling puts and calls of the Common Stock, or entering into any other transaction while serving as Directors or executive officers of the Company that reflects speculation about the Common Stock price or that might place their financial interests against the financial interests of the Company.
No Unapproved Trading Plans
– Directors and our NEOs are prohibited from entering into securities trading plans pursuant to SEC Rule 10b5-1 without pre-approval; further, no Director or any executive officer may trade in our Common Stock without pre-clearance.
|
|||||||
|
FY 2024 Base Salary
($)
|
FY 2023 Base Salary
($)
|
% increase | |||||||||
|
Julien R. Mininberg
(1)
|
1,250,000 | 1,250,000 | — | % | |||||||
|
Noel M. Geoffroy
(2)
|
800,000 | 575,000 | 39 | % | |||||||
|
Brian L. Grass
(3)
|
600,000 | — | — | % | |||||||
|
Tessa N. Judge
(4)
|
496,500 | 475,000 | 5 | % | |||||||
|
46
|
Helen of Troy | ||||
| 2024 Proxy Statement |
47
|
||||
| Performance Metric | Rationale | ||||
|
Adjusted Income
(1)(2)
|
Provides focus on profitable growth and expense management | ||||
|
Net Sales
(2)
|
Reinforces sustaining overall growth under our business strategy | ||||
| Performance Metric | Threshold | Target | Maximum | Weighting | ||||||||||
| Adjusted Income | $196.5 million | $231.1 million | $254.2 million | 80% | ||||||||||
| Net Sales | $1.762 billion | $2.073 billion | $2.280 billion | 20% | ||||||||||
| Name | Threshold | Target | Maximum | ||||||||
| Ms. Geoffroy | 62.5% | 125% | 250 | % | |||||||
|
Mr. Grass
(1)
|
42.5% | 85% | 170 | % | |||||||
| Ms. Judge | 30% | 60% | 120 | % | |||||||
|
48
|
Helen of Troy | ||||
|
Performance
Metric |
Weighting | Threshold | Target | Maximum |
Performance
as % of
Target
|
Payout
Percentage |
||||||||||||||||||||
|
Adjusted
Income |
80%
|
$196.5 million
|
$231.1 million
|
$254.2 million
|
||||||||||||||||||||||
|
92.4%
|
72.4%
|
||||||||||||||||||||||||
| Net Sales |
20%
|
$1.762 billion
|
$2.073 billion
|
$2.280 billion
|
||||||||||||||||||||||
|
96.7%
|
91.8%
|
||||||||||||||||||||||||
| Name |
Annual
Incentive
Paid
|
Blended
Percentage
of Target
|
|||||||||
| Mr. Mininberg | $1,980,866 | 76.3 | % |
(1)
|
|||||||
| Ms. Geoffroy | $782,442 | 76.3 | % | ||||||||
|
Mr. Grass
|
$164,632 | 76.3 | % |
(2)
|
|||||||
| Ms. Judge | $235,586 | 76.3 | % | ||||||||
| 2024 Proxy Statement |
49
|
||||
| Performance Metric | Weighting | Rationale | ||||||
|
Cumulative Adjusted Diluted EPS
(1)
|
50% | Viewed by our shareholders as an important reflection of the Company’s financial health and it measures how the Company is performing with respect to profitability and value creation. | ||||||
|
Relative Total Shareholder Return
(2)
|
50% | Provides a direct link between each NEO’s compensation and shareholder results, allowing their performance to be judged in comparison to peer group performance, while also allowing positive and negative adjustments for unexpected market conditions. The relative total shareholder return metric makes the performance of the Company’s Common Stock a targeted incentive. | ||||||
|
50
|
Helen of Troy | ||||
| Name | Grant Type |
Grant Date Fair
Value at Target
($)
|
Threshold
Shares
(#)
|
Target
Shares
(#)
|
Maximum
Shares
(#)
|
|||||||||||||||||||||
| Mr. Mininberg | Performance RSA | $6,700,000 | 30,221 | 60,442 | 120,884 | |||||||||||||||||||||
| Ms. Geoffroy | Performance RSA | $1,200,000 | 5,413 | 10,825 | 21,650 | |||||||||||||||||||||
|
Mr. Grass
(1)
|
Performance RSA | $345,000 | 1,611 | 3,222 | 6,444 | |||||||||||||||||||||
| Ms. Judge | Performance RSA | $475,000 | 2,143 | 4,285 | 8,570 | |||||||||||||||||||||
| NEO | Grant Type |
Grant Date Fair
Value at Target
($)
|
Threshold
Shares
(#)
|
Target
Shares
(#)
|
Maximum
Shares
(#)
|
|||||||||||||||||||||
| Mr. Mininberg | Performance RSA | $5,200,000 | 12,026 | 24,051 | 48,102 | |||||||||||||||||||||
|
Mr. Grass
|
Performance RSA | $1,147,500 | 2,654 | 5,307 | 10,614 | |||||||||||||||||||||
| 2024 Proxy Statement |
51
|
||||
|
52
|
Helen of Troy | ||||
| 2024 Proxy Statement |
53
|
||||
|
54
|
Helen of Troy | ||||
| 2024 Proxy Statement |
55
|
||||
|
Name and
Principal Position |
Fiscal
Year
|
Salary
($)
|
Stock
Awards
($)
(1)
|
Non-Equity
Incentive Plan
Compensation
($)
(2)
|
All Other
Compensation
($)
(3)
|
Total
($)
|
||||||||||||||||||||||||||
|
Julien R. Mininberg,
CEO
|
2024
|
1,250,000 | 6,700,000 |
(4)
|
1,980,866 | 75,556 | 10,006,422 | |||||||||||||||||||||||||
|
2023
|
1,250,000 | 6,700,000 | — | 15,812 | 7,965,812 | |||||||||||||||||||||||||||
|
2022
|
1,150,000 | 5,207,000 | 3,380,381 | 8,796 | 9,746,177 | |||||||||||||||||||||||||||
|
Noel M. Geoffroy,
COO
(6)
|
2024
|
800,000 | 1,600,000 |
(5)
|
782,442 | 17,925 | 3,200,367 | |||||||||||||||||||||||||
|
2023
|
442,308 | 1,816,000 | — | 3,501 | 2,261,809 | |||||||||||||||||||||||||||
|
Brian L. Grass,
CFO
(6)
|
2024
|
1,603,846 | 1,140,000 |
(7)
|
164,632 | 1,858 | 2,910,336 | |||||||||||||||||||||||||
|
2023
|
— | — | — | — | — | |||||||||||||||||||||||||||
|
2022
|
388,864 | 1,537,000 | 433,972 | 43,730 | 2,403,566 | |||||||||||||||||||||||||||
|
Tessa N. Judge,
CLO
(6)
|
2024
|
496,500 | 950,000 |
(8)
|
235,586 | 9,621 | 1,691,707 | |||||||||||||||||||||||||
|
2023
|
475,000 | 800,000 | — | 8,475 | 1,283,475 | |||||||||||||||||||||||||||
|
Matthew J. Osberg,
Former CFO
|
2024
|
96,923 |
(9)
|
1,100,000 |
(10)
|
— |
|
21,238 | 1,218,161 | |||||||||||||||||||||||
|
2023
|
575,000 | 800,000 | — | 191,102 | 1,566,102 | |||||||||||||||||||||||||||
|
2022
|
406,191 | 257,000 | 369,215 | 14,266 | 1,046,672 | |||||||||||||||||||||||||||
| Name |
401(k) Plan
($) |
Group Life Insurance
($)
|
Unused Vacation
($) |
Other
($) |
Total
($)
|
||||||||||||||||||
| Mr. Mininberg | 23,142 | 4,336 | 48,078 | — | 75,556 | ||||||||||||||||||
| Ms. Geoffroy | 14,769 | 2,006 | — | 1,150 |
(A)
|
17,925 | |||||||||||||||||
| Mr. Grass | — | 1,858 | — | — | 1,858 | ||||||||||||||||||
| Ms. Judge | 7,599 | 872 | — | 1,150 |
(A)
|
9,621 | |||||||||||||||||
| Mr. Osberg | 5,554 | 291 | 15,393 | — | 21,238 | ||||||||||||||||||
|
56
|
Helen of Troy | ||||
| 2024 Proxy Statement |
57
|
||||
|
58
|
Helen of Troy | ||||
| Name |
Grant Date
|
Estimated Future Payouts
Under Non-Equity Incentive
Plan Awards
(1)
|
Estimated Future Payouts
Under Equity Incentive
Plan Awards
(2)
|
All Other
Stock
Awards;
Number
of Shares
of Stock
or Units
(#)
|
Grant Date
Fair Value
of Stock
Awards
(3)
($)
|
|||||||||||||||||||||||||||||||||
|
Threshold
($)
|
Target
($)
|
Maximum
($)
|
Threshold
(#)
|
Target
(#)
|
Maximum
(#)
|
|||||||||||||||||||||||||||||||||
|
Julien R. Mininberg,
CEO
|
||||||||||||||||||||||||||||||||||||||
|
Annual Incentive Award
|
1,250,000 | 2,500,000 | 4,000,000 | |||||||||||||||||||||||||||||||||||
|
Performance RSAs
|
3/1/2023 | 30,221 | 60,442 | 120,884 | 6,700,000 | |||||||||||||||||||||||||||||||||
|
Noel M. Geoffroy,
COO
|
||||||||||||||||||||||||||||||||||||||
|
Annual Incentive Award
|
500,000 | 1,000,000 | 2,000,000 | |||||||||||||||||||||||||||||||||||
|
Performance RSAs
|
3/1/2023 | 5,413 | 10,825 | 21,650 | 1,200,000 | |||||||||||||||||||||||||||||||||
|
Time-Vested RSAs
|
3/1/2023 | 3,608 |
(4)
|
400,000 | ||||||||||||||||||||||||||||||||||
|
Brian L. Grass,
CFO
|
||||||||||||||||||||||||||||||||||||||
|
Annual Incentive Award
(5)
|
107,885 | 215,769 | 431,538 | |||||||||||||||||||||||||||||||||||
|
Performance RSAs
|
10/5/2023 | 1,611 | 3,222 | 6,444 |
(6)
|
345,000 | ||||||||||||||||||||||||||||||||
|
Time-vested RSAs
|
10/5/2023 | 3,221 |
(6)(7)
|
345,000 | ||||||||||||||||||||||||||||||||||
|
Time-Vested RSUs
|
3/21/2023 | 4,876 |
(8)
|
450,000 | ||||||||||||||||||||||||||||||||||
|
Tessa N. Judge,
CLO
|
||||||||||||||||||||||||||||||||||||||
|
Annual Incentive Award
|
148,950 | 297,900 | 595,800 | |||||||||||||||||||||||||||||||||||
|
Performance RSAs
|
3/1/2023 | 2,143 | 4,285 | 8,570 | 475,000 | |||||||||||||||||||||||||||||||||
|
Time-Vested RSAs
|
3/1/2023 | 4,285 |
(4)
|
475,000 | ||||||||||||||||||||||||||||||||||
|
Matthew J. Osberg,
former CFO
|
||||||||||||||||||||||||||||||||||||||
|
Annual Incentive Award
|
255,000 | 510,000 | 1,020,000 | |||||||||||||||||||||||||||||||||||
|
Performance RSAs
|
3/1/2023 | 2,481 | 4,961 | 9,922 | 550,000 | |||||||||||||||||||||||||||||||||
|
Time-Vested RSAs
|
3/1/2023 | 4,961 |
(4)
|
550,000 | ||||||||||||||||||||||||||||||||||
| 2024 Proxy Statement |
59
|
||||
| Stock Awards | ||||||||||||||||||||||||||
| Name |
Equity Incentive Plan
Awards: Number
of Unearned Shares,
Units or Other Rights
That Have
Not Vested
(#)
|
Equity Incentive Plan
Awards: Market or Payout
Value of Unearned
Shares, Units or
Other Rights That
Have Not Vested
($)
(1)
|
||||||||||||||||||||||||
|
Julien R. Mininberg,
CEO
|
32,825 |
(2)
|
4,103,125 | |||||||||||||||||||||||
| 60,442 |
(3)
|
7,555,250 | ||||||||||||||||||||||||
| 10 |
(4)
|
1,250 | ||||||||||||||||||||||||
|
Noel M. Geoffroy,
COO
|
3,691 |
(2)
|
461,375 | |||||||||||||||||||||||
| 10,825 |
(3)
|
1,353,125 | ||||||||||||||||||||||||
| 1,292 |
(5)
|
161,500 | ||||||||||||||||||||||||
| 1,230 |
(6)
|
153,750 | ||||||||||||||||||||||||
| 3,608 |
(7)
|
451,000 | ||||||||||||||||||||||||
|
Brian L. Grass,
CFO
|
3,222 |
(3)
|
402,750 | |||||||||||||||||||||||
| 197 |
(8)
|
24,625 | ||||||||||||||||||||||||
| 3,221 |
(9)
|
402,625 | ||||||||||||||||||||||||
|
Tessa N. Judge,
CLO
|
2,940 |
(2)
|
367,500 | |||||||||||||||||||||||
| 4,285 |
(3)
|
535,625 | ||||||||||||||||||||||||
| 237 |
(8)
|
29,625 | ||||||||||||||||||||||||
| 979 |
(6)
|
122,375 | ||||||||||||||||||||||||
| 4,285 |
(7)
|
535,625 | ||||||||||||||||||||||||
| 10 |
(4)
|
1,250 | ||||||||||||||||||||||||
|
60
|
Helen of Troy | ||||
| Stock Awards | ||||||||||||||
| Name |
Number of Shares
Acquired on Vesting
(#)
|
Value Realized
on Vesting
($)
|
||||||||||||
|
Julien R. Mininberg,
CEO
|
30,550 | 2,966,711 | ||||||||||||
|
Noel M. Geoffroy,
COO
|
2,583 | 244,326 | ||||||||||||
|
Brian L. Grass,
CFO
|
12,537 | 1,322,206 | ||||||||||||
|
Tessa N. Judge,
CLO
|
2,045 | 205,364 | ||||||||||||
|
Matthew J. Osberg,
former CFO
|
1,173 | 118,464 | ||||||||||||
| Plan Category |
Number of securities to
be issued upon exercise
of outstanding options,
warrants, and rights
(1)
|
Weighted-average
exercise price of
outstanding options,
warrants, and rights
(2)
|
Number of securities remaining
available for future issuance
under equity compensation
plans (excluding securities
reflected in the first column)
(3)
|
|||||||||||
|
Equity compensation plans
approved by security holders |
28,407 | $ | 72.46 | 1,294,043 | ||||||||||
| 2024 Proxy Statement |
61
|
||||
|
62
|
Helen of Troy | ||||
| 2024 Proxy Statement |
63
|
||||
| Triggering Event | Compensation Component | How Paid | Payout | ||||||||
|
Termination in Connection with Retirement
(1)(2)
|
▪
Continued vesting of any outstanding Performance RSAs based on actual performance
(3)
|
Scheduled vesting date | $11,658,375 | ||||||||
|
▪
Health benefits
(4)
|
Over time | $56,806 | |||||||||
| Total | $11,715,181 | ||||||||||
|
64
|
Helen of Troy | ||||
| Triggering Event | Compensation Component | How Paid | Payout | ||||||||
| Death |
▪
Death benefits
(5)
|
Third party payment | $750,000 | ||||||||
|
Disability
(1)
|
▪
Disability benefits
(5)
|
Third party payment | $3,967,700 | ||||||||
|
Termination for Good Reason or without Cause (and Not in Connection with a Change of Control)
(1)(2)
|
▪
Cash payment of 1 times base salary and target annual incentive
(6)(7)
|
Over 24 months | $1,800,000 | ||||||||
|
▪
Pro rata portion of any outstanding Performance RSAs based on actual performance
(8)
|
Scheduled vesting date | $755,653 | |||||||||
|
▪
Pro rata portion of any time-vested RSAs
(8)
|
Within 60 days | $548,929 | |||||||||
|
▪
Health benefits
(9)
|
Over time | $26,920 | |||||||||
| Total | $3,131,502 | ||||||||||
|
Termination for Good Reason or without Cause (and in Connection with a Change of Control)
(1)(2)(10)
|
▪
Cash payment of 1.5 times base salary and 1.5 times target annual incentive
(6)(7)
|
Within 75 days | $2,700,000 | ||||||||
|
▪
Accelerated vesting at target of any outstanding Performance RSAs
(11)
|
Within 60 days | $1,814,500 | |||||||||
|
▪
Accelerated vesting of any time-vested RSAs
(11)
|
Within 60 days | $766,250 | |||||||||
|
▪
Health benefits
(9)
|
Over time | $40,380 | |||||||||
| Total | $5,321,130 | ||||||||||
| Triggering Event | Compensation Component | How Paid | Payout | ||||||||
| Death |
▪
Death benefits
(5)
|
Third party payment | $750,000 | ||||||||
|
Disability
(1)
|
▪
Disability benefits
(5)
|
Third party payment | $3,808,400 | ||||||||
| Retirement |
▪
Continued vesting of any outstanding Performance RSAs based on actual performance
(12)
|
Scheduled vesting date | $— | ||||||||
|
▪
Continued vesting of a pro rata portion of any time-vested RSAs
((12)
|
Scheduled vesting date | $24,625 | |||||||||
|
▪
Health benefits
(9)
|
Over time | $40,527 | |||||||||
| Total | $65,152 | ||||||||||
|
Termination for Good Reason or without Cause (and Not in Connection with a Change of Control)
(1)(2)
|
▪
Cash payment of 1 times base salary and target annual incentive
(6)(7)
|
Over 24 months | $1,110,000 | ||||||||
|
▪
Pro rata portion of any outstanding Performance RSAs based on actual performance
(8)
|
Scheduled vesting date | $132,908 | |||||||||
|
▪
Pro rata portion of any time-vested RSAs
(8)
|
Within 60 days | $123,238 | |||||||||
|
▪
Health benefits
(9)
|
Over time | $27,018 | |||||||||
| Total | $1,393,164 | ||||||||||
|
Termination for Good Reason or without Cause (and in Connection with a Change of Control)
(1)(2)(10)
|
▪
Cash payment of 1.5 times base salary and 1.5 times target annual incentive
(6)(7)
|
Within 75 days | $1,665,000 | ||||||||
|
▪
Accelerated vesting at target of any outstanding Performance RSAs
(11)
|
Within 60 days | $1,066,125 | |||||||||
|
▪
Accelerated vesting of any time-vested RSAs
(11)
|
Within 60 days | $427,250 | |||||||||
|
▪
Health benefits
(9)
|
Over time | $40,527 | |||||||||
| Total | $3,198,902 | ||||||||||
| 2024 Proxy Statement |
65
|
||||
| Triggering Event | Compensation Component | How Paid | Payout | ||||||||
| Death |
▪
Death benefits
(5)
|
Third party payment | $750,000 | ||||||||
|
Disability
(1)
|
▪
Disability benefits
(5)
|
Third party payment | $7,769,200 | ||||||||
|
Termination for Good Reason or without Cause (and Not in Connection with a Change of Control)
(1)(2)
|
▪
Cash payment of 1 times base salary and target annual incent
ive
(6)(7)
|
Over 24 months | $794,400 | ||||||||
|
▪
Pro rata portion of any outstanding Performance RSAs based on actual performa
nce
(8)
|
Scheduled vesting date | $422,981 | |||||||||
|
▪
Pro rata portion of any time-vested RSAs
(8)
|
Within 60 days | $458,822 | |||||||||
|
▪
Health benefits
(9)
|
Over time | $16,139 | |||||||||
| Total | $1,692,342 | ||||||||||
|
Termination for Good Reason or without Cause (and in Connection with a Change of Control)
(1)(2)(10)
|
▪
Cash payment of 1.5 times base salary and 1.5 times target annual incentive
(6)(7)
|
Within 75 days | $1,191,600 | ||||||||
|
▪
Accelerated vesting at target of any outstanding Performance RSAs
(11)
|
Within 60 days | $1,080,875 | |||||||||
|
▪
Accelerated vesting of any time-vested RSAs
(11)
|
Within 60 days | $688,875 | |||||||||
|
▪
Health benefits
(9)
|
Over time | $24,209 | |||||||||
| Total | $2,985,559 | ||||||||||
| (1) | The terms “disability,” “good reason,” “cause” and “change of control” each have the same meanings as defined in the Severance Agreements for our other NEOs. | ||||
| (2) | In the event of each of our other NEO’s termination without cause or for good reason, all payments and benefits due to him or her, other than any portion of unpaid base salary and any payment or benefit otherwise required by any rule or regulation issued by any state or federal governmental agency, will be contingent upon that other NEO’s execution of a general release of all claims against the Company, its affiliates and their respective and former Directors, associates and agents to the maximum extent permitted by law, pursuant to the Severance Agreement for our other NEOs. | ||||
| (3) |
Under the Mininberg Employment Agreement, in the event of a termination of employment by the CEO for retirement, our CEO was eligible for the continued vesting of all outstanding, unearned Performance RSAs based on actual performance of the Company for the applicable performance periods. The amount disclosed in the table for Performance RSAs reflects 0% actual performance achievement for the RSAs with the performance period ended February 29, 2024 and assumes target performance for RSAs with performance periods ending February 28, 2025 and February 28, 2026.
|
||||
| (4) | Reflects the estimated value of the monthly employer portion of the premium payments to receive “Retiree Coverage” under the Company’s health plan until December 26, 2029 for our CEO and his spouse. Under the terms of the Mininberg Employment Agreement, our CEO had the right to elect to either continue coverage under the Company’s health plan under COBRA or to receive “Retiree Coverage” under the Company’s health plan until December 2029 (subject to earlier termination under certain conditions including if he is covered by or eligible for coverage under another health insurance policy). Mr. Mininberg elected Retiree Coverage and is obligated to pay the employee portion of the premium and the Company will pay the employer portion of such premium. If COBRA coverage had been elected, our CEO would have been obligated to pay the full cost (employer and employee premium amounts) for such COBRA coverage. | ||||
| (5) | Represents third party payments from insurers. In the event of death, this would include the payment under a life insurance policy in the amount of $750,000. In the event of disability, the amount of the payment(s) under a disability policy would depend upon the circumstances and nature of the disability, with a maximum payment of $25,000 per month until age 67. | ||||
| (6) | In accordance with the Severance Agreements, the amounts represent 12 months of the other NEO’s respective base salary payable in the event of a termination of employment by our other NEOs for good reason or by the Company without cause (not in connection with a change of control) and 18 months base salary payable in the event of a termination of employment by our other NEOs for good reason or by the Company without cause in connection with a change of control. | ||||
| (7) | Under the Severance Agreement, our other NEOs would have been entitled to receive (a) 100% of his or her target annual incentive for the performance period in which our other NEO is terminated in the event of a termination of employment by our other NEO for good reason or by the Company without cause (not in connection with a change of control) and (b) 150% of his or her target annual incentive for the performance period in which our other NEO is terminated in the event of a termination of employment by our other NEO for good reason or by the Company without cause in connection with a change of control, which are reflected in the table above. | ||||
| (8) |
Under the Severance Agreement, in the event of a termination of employment by an other NEO for good reason or by the Company without cause (not in connection with a change of control), a pro rata portion of any outstanding Performance RSAs will vest based on the actual performance of the Company for the applicable performance periods during which the other NEO’s employment was terminated. The amount disclosed in the table for Performance RSAs is based on 0% actual performance achievement for the performance period ended February 29, 2024 and assumes target performance for RSAs with performance periods ending February 28, 2025 and February 28, 2026. Additionally, a pro rata portion of any outstanding installment of time-vested RSAs will vest under the terms of the Severance Agreements.
|
||||
|
66
|
Helen of Troy | ||||
| (9) | Reflects the estimated value of 12 monthly COBRA payments for a termination not in connection with a change of control and 18 monthly COBRA payments for a termination in connection with a change of control. To the extent permitted by benefit plans of the Company and its subsidiaries, and applicable law, under the Severance Agreement, our other NEOs are entitled to the continuation of health insurance benefits under COBRA. In the event of a termination of employment by our other NEOs for good reason or by the Company without cause not in connection with a change of control, our other NEOs and his or her families are entitled to the continuation of health insurance benefits for a maximum of 12 months after the date of termination or until our other NEO is covered by or eligible for coverage under another health insurance policy, if that occurs earlier than 12 months. In the event of an other NEO’s retirement or termination of employment by the other NEO for good reason or by the Company without cause in connection with a change of control, those benefits extend to 18 months. | ||||
| (10) |
Under the Severance Agreement, in the event of a termination of employment by the NEO for good reason or by the Company without cause in connection with a change of control, the NEO is paid up to the target amount of his or her annual incentive for the fiscal year in which he or she is terminated to the extent not paid or earned for that fiscal year. The amount is determined on a pro rata basis if the other NEO has been employed by the Company less than the full fiscal year. For fiscal year 2024, the target amount of the NEO’s annual incentive that would have been paid under this termination and change of control event, was $1,000,000 for Ms. Geoffroy and $297,900 for Ms. Judge.
|
||||
| (11) |
Under the Severance Agreement, in the event of a termination of employment by our other NEOs for good reason or by the Company without cause in connection with a change of control, all Performance RSAs vest at target and all unvested, time-vested RSAs will fully vest, which is reflected in the table above. The amount disclosed in the table assumes target performance for RSAs with performance periods ending February 29, 2024, February 28, 2025, and February 28, 2026. Any outstanding equity awards issued to our other NEOs that are not assumed in connection with a change of control will vest immediately in accordance with the terms of the 2018 Stock Plan.
|
||||
| (12) |
Under the Severance Agreement, in the event of a retirement termination of employment, our CFO is eligible for the continued vesting of all Performance RSAs granted at least six months prior to his date of retirement based on actual performance of the Company for the applicable performance periods and continued vesting of a pro rata portion of any unvested tranche of time-vested RSAs granted at least six months prior to his date of retirement. The amount disclosed in the table for Performance RSAs is based on 0% actual performance achievement for the performance period ended February 29, 2024.
|
||||
| (13) | As of February 29, 2024, the Severance Agreement previously entered into by the Company and Ms. Geoffroy governed her compensation that would be paid in the event of such termination and/or change of control. Effective March 1, 2024, the Geoffroy Employment Agreement replaced her Severance Agreement. | ||||
| 2024 Proxy Statement |
67
|
||||
|
68
|
Helen of Troy | ||||
| 2024 Proxy Statement |
69
|
||||
|
70
|
Helen of Troy | ||||
| 2024 Proxy Statement |
71
|
||||
| Fiscal Year |
Summary
Compensation
Table Total
for CEO
($)
(1)
|
Compensation
Actually Paid
to CEO
($)
(2)
|
Average
Summary
Compensation
Table Total
for Other NEOs
($)
(3)
|
Average
Compensation
Actually Paid
to Other NEOs
($)
(4)
|
Value of Fixed $100
Investment Based On: |
Net
Income ($) |
Adjusted Income
($)
(7)
|
||||||||||||||||||||||
|
Total
Shareholder
Return
($)
(5)
|
Dow Jones
U.S. Personal
Products Index
($)
(6)
|
||||||||||||||||||||||||||||
| 2024 |
|
|
|
|
|
|
|
|
|||||||||||||||||||||
| 2023 |
|
(
|
|
|
|
|
|
|
|||||||||||||||||||||
| 2022 |
|
|
|
|
|
|
|
|
|||||||||||||||||||||
| 2021 |
|
|
|
|
|
|
|
|
|||||||||||||||||||||
| Fiscal Year | ||||||||||||||
| Compensation Element | 2024 | 2023 | 2022 | 2021 | ||||||||||
|
SCT Reported Total Compensation
(A)
|
$
|
$
|
$
|
$
|
||||||||||
|
Minus Aggregate SCT Reported Equity Compensation
(B)
|
(
|
(
|
(
|
(
|
||||||||||
|
Plus Year-End Fair Value of Awards Granted During the Covered FY & Outstanding
(C)
|
|
|
|
|
||||||||||
|
Plus or Minus (as applicable) Year-Over-Year Change in Fair Value of Awards Granted During Prior FY(s) & Outstanding
(C)
|
(
|
(
|
|
|
||||||||||
|
Plus Vesting Date Fair Value of Awards Granted & Vested During the Covered FY
(C)
|
|
|
|
|
||||||||||
|
Plus or Minus (as applicable) Year-Over-Year Change in Fair Value of Awards Granted During Prior FY(s) & Vesting During Covered FY
(C)
|
(
|
(
|
|
(
|
||||||||||
|
Minus Prior FY End Value of Awards Determined to Fail to Meet Vesting Conditions During Covered FY
(C)
|
|
|
|
|
||||||||||
|
Plus Value of Dividends or Other Earnings Paid on Stock Awards Not Otherwise Included
(C)
|
|
|
|
|
||||||||||
| Compensation Actually Paid |
$
|
($
|
$
|
$
|
||||||||||
|
72
|
Helen of Troy | ||||
| Fiscal Year | ||||||||||||||
| Compensation Element | 2024 | 2023 | 2022 | 2021 | ||||||||||
|
SCT Reported Total Compensation
(A)
|
$
|
$
|
$
|
$
|
||||||||||
|
Minus Aggregate SCT Reported Equity Compensation
(B)
|
(
|
(
|
(
|
(
|
||||||||||
|
Plus Year-End Fair Value of Awards Granted During the Covered FY & Outstanding
(C)
|
|
|
|
|
||||||||||
|
Plus or Minus (as applicable) Year-Over-Year Change in Fair Value of Awards Granted During Prior FY(s) & Outstanding
(C)
|
(
|
(
|
(
|
|
||||||||||
|
Plus Vesting Date Fair Value of Awards Granted & Vested During the Covered FY
(C)
|
|
|
|
|
||||||||||
|
Plus or Minus (as applicable) Year-Over-Year Change in Fair Value of Awards Granted During Prior FY(s) & Vesting During Covered FY
(C)
|
(
|
(
|
|
|
||||||||||
|
Minus Prior FY End Value of Awards Determined to Fail to Meet Vesting Conditions During Covered FY
(C)
|
(
|
|
|
|
||||||||||
|
Plus Value of Dividends or Other Earnings Paid on Stock Awards Not Otherwise Included
(C)
|
|
|
|
|
||||||||||
| Compensation Actually Paid |
$
|
$
|
$
|
$
|
||||||||||
| Incentive Award | Financial Metric | ||||
| Annual Incentive Awards |
|
||||
|
|
|||||
| Long-Term Incentive Awards |
|
||||
|
|
|||||
| 2024 Proxy Statement |
73
|
||||
|
74
|
Helen of Troy | ||||
|
Proposal 3: Appointment of Auditor and Independent Registered Public Accounting Firm for the 2025 Fiscal Year and Authorization of the Audit Committee of the Board of Directors to Set the Auditor’s Remuneration
Under Bermuda law, our shareholders have the responsibility to appoint the auditor and independent registered public accounting firm of the Company to hold office until the close of the next annual general meeting and are able to authorize the Audit Committee of the Board of Directors to set the auditors’ remuneration.
The Audit Committee has nominated Grant Thornton LLP as the Company’s auditor and independent registered public accounting firm for fiscal year 2025. A representative of Grant Thornton LLP, the Company’s auditor and independent registered public accounting firm for fiscal year 2024, is expected to be virtually present at the Annual Meeting with the opportunity to make a statement if the representative desires to do so. The Grant Thornton LLP representative is also expected to be available to respond to appropriate questions from shareholders.
Vote Required for Approval and Recommendation
The affirmative vote of a majority of the votes cast at the Annual Meeting is required to appoint Grant Thornton LLP as our auditor and independent registered public accounting firm for fiscal year 2025 and authorize the Audit Committee to set the auditor’s remuneration as described in this Proposal 3.
|
|||||||||||||||||
| ü | THE BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR” THIS PROPOSAL. | ||||||||||||||||
| 2024 Proxy Statement |
75
|
||||
| Type of Fee | 2024 | 2023 | ||||||||||||
| Audit Fees | $ | 1,383,800 | $ | 1,289,600 | ||||||||||
| Audit-Related Fees | 31,000 | 30,000 | ||||||||||||
| Tax Fees | 11,500 | 6,700 | ||||||||||||
| All Other Fees | — | — | ||||||||||||
| Total | $ | 1,426,300 | $ | 1,326,300 | ||||||||||
|
76
|
Helen of Troy | ||||
| 2024 Proxy Statement |
77
|
||||
| Name of Beneficial Owner |
Number of
Common
Shares
Beneficially
Owned
|
Percent* | ||||||
|
Julien R. Mininberg
(1)
|
179,215 | ** | ||||||
| Noel M. Geoffroy | 3,616 | ** | ||||||
|
Brian L. Grass
|
30,478 | ** | ||||||
| Tessa N. Judge | 8,195 | ** | ||||||
| Vincent D. Carson | 13,758 | ** | ||||||
| Darren G. Woody | 8,054 | ** | ||||||
| Timothy F. Meeker | 7,354 | ** | ||||||
| Beryl B. Raff | 6,774 | ** | ||||||
| Thurman K. Case | 4,639 | ** | ||||||
| Krista L. Berry | 4,461 | ** | ||||||
| Elena B. Otero | 1,679 | ** | ||||||
| Tabata L. Gomez | 1,679 | ** | ||||||
|
All current Directors, nominees for Director and executive officers as a group
(11 persons)
(2)
|
90,687 | ** | ||||||
|
FMR LLC
(3)
245 Summer Street
Boston, Massachusetts 02210
|
3,333,213 | 14.32 | % | |||||
|
BlackRock, Inc.
(4)
50 Hudson Yards
New York, New York 10001
|
2,822,079 | 12.12 | % | |||||
|
The Vanguard Group, Inc.
(5)
100 Vanguard Boulevard
Malvern, Pennsylvania 19355
|
2,403,637 | 10.32 | % | |||||
|
Cooke & Bieler LP
(6)
Two Commerce Square
2001 Market Street, Suite 4000
Philadelphia, Pennsylvania 19103
|
1,998,725 | 8.58 | % | |||||
|
Capital Research Global Investors
(7)
A division of Capital Research and Management Company (CRMC)
333 South Hope Street, 55th Fl
Los Angeles, California 90071
|
1,761,029 | 7.56 | % | |||||
|
JPMorgan Chase & Co.
(8)
383 Madison Avenue
New York, New York 10179
|
1,178,180 | 5.06 | % | |||||
|
78
|
Helen of Troy | ||||
| 2024 Proxy Statement |
79
|
||||
|
80
|
Helen of Troy | ||||
| 2024 Proxy Statement |
81
|
||||
|
82
|
Helen of Troy | ||||
| 2024 Proxy Statement |
83
|
||||
|
84
|
Helen of Troy | ||||
|
Fiscal Years Ended Last Day of February,
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted EPS as reported (GAAP) | $ | 7.03 | $ | 5.95 | $ | 9.17 | $ | 10.08 | $ | 6.02 | $ | 6.62 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Bed, Bath & Beyond bankruptcy, net of tax
|
0.17 | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Gain on sale of distribution and office facilities, net of tax
|
(1.06) | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPA compliance costs, net of tax | — | 0.96 | 1.31 | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Gain from insurance recoveries, net of tax | — | (0.40) | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tax reform | — | — | — | (0.37) | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Asset impairment charges, net of tax | — | — | — | 0.30 | 1.44 | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Restructuring charges, net of tax | 0.77 | 1.12 | 0.02 | 0.01 | 0.12 | 0.13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acquisition-related expenses, net of tax | — | 0.12 | 0.10 | — | 0.10 | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Subtotal | 6.92 | 7.75 | 10.58 | 10.02 | 7.68 | 6.75 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Amortization of intangible assets, net of tax | 0.66 | 0.67 | 0.48 | 0.67 | 0.79 | 0.53 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-cash share-based compensation, net of tax | 1.33 | 1.03 | 1.30 | 0.97 | 0.83 | 0.79 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjusted diluted EPS (non-GAAP) | $ | 8.91 | $ | 9.45 | $ | 12.36 | $ | 11.65 | $ | 9.30 | $ | 8.06 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Weighted average shares of common stock used in computing diluted EPS | 23,970 | 24,090 | 24,410 | 25,196 | 25,322 | 26,303 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2024 Proxy Statement |
85
|
||||
| Fiscal Year Ended Last Day of February, | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Operating income as reported (GAAP) | $260,589 | 13.0 | % | $211,791 | 10.2 | % | $272,550 | 12.3 | % | $281,488 | 13.4 | % | $178,251 | 10.4 | % | $199,379 | 12.7 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Bed, Bath & Beyond bankruptcy | 4,213 | 0.2 | % | — | — | % | — | — | % | — | — | % | — | — | % | — | — | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Gain on sale of distribution and office facilities | (34,190) | (1.7) | % | — | — | % | — | — | % | — | — | % | — | — | % | — | — | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPA compliance costs | — | — | % | 23,573 | 1.1 | % | 32,354 | 1.5 | % | — | — | % | — | — | % | — | — | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Gain from insurance recoveries | — | — | % | (9,676) | (0.5) | % | — | — | % | — | — | % | — | — | % | — | — | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Asset impairment charges | — | — | % | — | — | % | — | — | % | 8,452 | 0.4 | % | 41,000 | 2.4 | % | — | — | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Restructuring charges | 18,712 | 0.9 | % | 27,362 | 1.3 | % | 380 | — | % | 350 | — | % | 3,313 | 0.2 | % | 3,586 | 0.2 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acquisition-related expenses | — | — | % | 2,784 | 0.1 | % | 2,424 | 0.1 | % | — | — | % | 2,546 | 0.1 | % | — | — | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Subtotal | 249,324 | 12.4 | % | 255,834 | 12.3 | % | 307,708 | 13.8 | % | 290,290 | 13.8 | % | 225,110 | 13.2 | % | 202,965 | 13.0 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Amortization of intangible assets | 18,326 | 0.9 | % | 18,322 | 0.9 | % | 12,764 | 0.6 | % | 17,643 | 0.8 | % | 21,271 | 1.2 | % | 14,204 | 0.9 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-cash share-based compensation | 33,872 | 1.7 | % | 26,753 | 1.3 | % | 34,618 | 1.6 | % | 26,418 | 1.3 | % | 22,929 | 1.3 | % | 22,053 | 1.4 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjusted operating income (non-GAAP) | $301,522 | 15.0 | % | $300,909 | 14.5 | % | $355,090 | 16.0 | % | $334,351 | 15.9 | % | $269,310 | 15.8 | % | $239,222 | 15.3 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
86
|
Helen of Troy | ||||
| Fiscal Year Ended Last Day of February, | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net income, as reported (GAAP) | $168,594 | $143,273 | $223,764 | $253,946 | $152,333 | $174,224 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest expense | 53,065 | 40,751 | 12,844 | 12,617 | 12,705 | 11,719 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Income tax expense | 40,448 | 28,016 | 36,202 | 15,484 | 13,607 | 13,776 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Depreciation and amortization | 51,499 | 44,683 | 35,829 | 37,718 | 37,409 | 29,927 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EBITDA (non-GAAP) | 313,606 | 256,723 | 308,639 | 319,765 | 216,054 | 229,646 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Add: Bed, Bath & Beyond bankruptcy | 4,213 | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Gain on sale of distribution and office facilities | (34,190) | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acquisition-related expenses | — | 2,784 | 2,424 | — | 2,546 | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPA compliance costs | — | 23,573 | 32,354 | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Gain on insurance recoveries | — | (9,676) | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Restructuring charges | 18,712 | 27,362 | 380 | 350 | 3,313 | 3,586 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Asset impairment charges | — | — | — | 8,452 | 41,000 | — | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-cash share-based compensation | 33,872 | 26,753 | 34,618 | 26,418 | 22,929 | 22,053 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjusted EBITDA (non-GAAP) | $336,213 | $327,519 | $378,415 | $354,985 | $285,842 | $255,285 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2024 Proxy Statement |
87
|
||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
Customers
| Customer name | Ticker |
|---|---|
| Williams-Sonoma, Inc. | WSM |
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|